{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:25:08Z","timestamp":1789043108793,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-12589-0","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T06:24:08Z","timestamp":1753770248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The role of selected NKG2DLs such as MICA, MICB and ULBP4 as potential markers in multiple sclerosis"],"prefix":"10.1038","volume":"15","author":[{"given":"Aleksandra","family":"Pogoda-Weso\u0142owska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"\u015awi\u0105tek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Synowiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zdanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacy","family":"Stachura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"Szewczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Pietras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"St\u0119pie\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"issue":"3","key":"12589_CR1","doi-asserted-by":"publisher","first-page":"a028936","DOI":"10.1101\/cshperspect.a028936","volume":"8","author":"H Lassmann","year":"2018","unstructured":"Lassmann, H. Multiple sclerosis pathology. Cold Spring Harb Perspect. Med. 8(3), a028936. https:\/\/doi.org\/10.1101\/cshperspect.a028936 (2018).","journal-title":"Cold Spring Harb Perspect. Med."},{"issue":"4 Pt 2","key":"12589_CR2","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/j.lpm.2015.01.001","volume":"44","author":"V Pantazou","year":"2015","unstructured":"Pantazou, V., Schluep, M. & Du Pasquier, R. Environmental factors in multiple sclerosis. Presse Med. 44(4 Pt 2), e113\u2013e120. https:\/\/doi.org\/10.1016\/j.lpm.2015.01.001 (2015).","journal-title":"Presse Med."},{"key":"12589_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10048-008-0156-y","volume":"10","author":"K Hemminki","year":"2009","unstructured":"Hemminki, K., Li, X., Sundquist, J., Hiller, J. & Sundquist, K. Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditions. Neurogenetics 10, 5\u201311. https:\/\/doi.org\/10.1007\/s10048-008-0156-y (2009).","journal-title":"Neurogenetics"},{"key":"12589_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature10251","volume":"476","author":"S Sawcer","year":"2011","unstructured":"Sawcer, S. et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476, 214\u2013219. https:\/\/doi.org\/10.1038\/nature10251 (2011).","journal-title":"Nature"},{"issue":"1","key":"12589_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1399-0039.2008.01066.x","volume":"72","author":"JL Fernandez-Morera","year":"2008","unstructured":"Fernandez-Morera, J. L. et al. Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility. Tissue Antigens. 72(1), 54\u201359. https:\/\/doi.org\/10.1111\/j.1399-0039.2008.01066.x (2008).","journal-title":"Tissue Antigens"},{"issue":"2","key":"12589_CR6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17(2), 162\u2013173. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2 (2018).","journal-title":"Lancet Neurol."},{"issue":"10076","key":"12589_CR7","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/S0140-6736(16)30959-X","volume":"389","author":"WJ Brownlee","year":"2017","unstructured":"Brownlee, W. J., Hardy, T. A., Fazekas, F. & Miller, D. H. Diagnosis of multiple sclerosis: progress and challenges. Lancet 389(10076), 1336\u20131346. https:\/\/doi.org\/10.1016\/S0140-6736(16)30959-X (2017).","journal-title":"Lancet"},{"key":"12589_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s00415-023-12081-7","volume":"271","author":"PGE Kennedy","year":"2024","unstructured":"Kennedy, P. G. E., George, W. & Yu, X. The elusive nature of the oligoclonal bands in multiple sclerosis. J. Neurol. 271, 116\u2013124. https:\/\/doi.org\/10.1007\/s00415-023-12081-7 (2024).","journal-title":"J. Neurol."},{"key":"12589_CR9","doi-asserted-by":"crossref","unstructured":"Song, Z. et al. Global research trends on the links between NfL and neurological disorders: A bibliometric analysis and review. Heliyon 10,15 (2024).","DOI":"10.1016\/j.heliyon.2024.e34720"},{"key":"12589_CR10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fneur.2019.00338","volume":"10","author":"KN Varhaug","year":"2019","unstructured":"Varhaug, K. N. et al. Neurofilament light chain as a biomarker in multiple sclerosis. Front. Neurol. 10, 338 (2019).","journal-title":"Front. Neurol."},{"issue":"22","key":"12589_CR11","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1212\/WNL.0000000000004683","volume":"89","author":"L Novakova","year":"2017","unstructured":"Novakova, L. et al. Monitoring disease activity in multiple sclerosis using serum neurofilament light protein. Neurology 89(22), 2230\u20132237. https:\/\/doi.org\/10.1212\/WNL.0000000000004683 (2017).","journal-title":"Neurology"},{"issue":"12","key":"12589_CR12","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1177\/1352458515623365","volume":"22","author":"J Kuhle","year":"2016","unstructured":"Kuhle, J. et al. Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity. Mult Scler. J. 22(12), 1550\u20131559. https:\/\/doi.org\/10.1177\/1352458515623365 (2016).","journal-title":"Mult Scler. J."},{"key":"12589_CR13","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3389\/fimmu.2018.01219","volume":"9","author":"M Babic","year":"2018","unstructured":"Babic, M. & Romagnani, C. The role of natural killer group 2, member D in chronic inflammation and autoimmunity. Front. Immunol. 9, 1219. https:\/\/doi.org\/10.3389\/fimmu.2018.01219 (2018).","journal-title":"Front. Immunol."},{"issue":"24","key":"12589_CR14","doi-asserted-by":"publisher","first-page":"17545","DOI":"10.3390\/ijms242417545","volume":"24","author":"L Wei","year":"2023","unstructured":"Wei, L., Xiang, Z. & Zou, Y. The role of NKG2D and its ligands in autoimmune diseases: new targets for immunotherapy. Int. J. Mol. Sci. 24(24), 17545. https:\/\/doi.org\/10.3390\/ijms242417545 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"12589_CR15","doi-asserted-by":"publisher","first-page":"104542","DOI":"10.1016\/j.msard.2023.104542","volume":"71","author":"A Carmena Moratalla","year":"2023","unstructured":"Carmena Moratalla, A. et al. Specific alterations in NKG2D\u2009+\u2009T lymphocytes in relapsing-remitting and progressive multiple sclerosis patients. Mult Scler. Relat. Disord. 71, 104542 (2023).","journal-title":"Mult Scler. Relat. Disord"},{"key":"12589_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fimmu.2019.00154","volume":"10","author":"L Legroux","year":"2019","unstructured":"Legroux, L. et al. NKG2D and its ligand MULT1 contribute to disease progression in a mouse model of multiple sclerosis. Front. Immunol. 10, 154. https:\/\/doi.org\/10.3389\/fimmu.2019.00154 (2019).","journal-title":"Front. Immunol."},{"issue":"1","key":"12589_CR17","doi-asserted-by":"publisher","first-page":"e1119","DOI":"10.1212\/NXI.0000000000001119","volume":"9","author":"A Carmena Moratalla","year":"2021","unstructured":"Carmena Moratalla, A. et al. Stress signal ULBP4, an NKG2D ligand, is upregulated in multiple sclerosis and shapes CD8\u2009+\u2009T-cell behaviors. Neurol. Neuroimmunol. Neuroinflamm. 9(1), e1119. https:\/\/doi.org\/10.1212\/NXI.0000000000001119 (2021).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"issue":"5","key":"12589_CR18","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1523\/JNEUROSCI.4402-06.2007","volume":"27","author":"P Saikali","year":"2007","unstructured":"Saikali, P. et al. NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis. J. Neurosci. 27(5), 1220\u20131228. https:\/\/doi.org\/10.1523\/JNEUROSCI.4402-06.2007 (2007).","journal-title":"J. Neurosci."},{"issue":"11","key":"12589_CR19","doi-asserted-by":"publisher","first-page":"e81455","DOI":"10.1371\/journal.pone.0081455","volume":"8","author":"T Ruck","year":"2013","unstructured":"Ruck, T. et al. CD4\u2009+\u2009NKG2D\u2009+\u2009T cells exhibit enhanced migratory and encephalitogenic properties in neuroinflammation. PLoS One. 8(11), e81455. https:\/\/doi.org\/10.1371\/journal.pone.0081455 (2013).","journal-title":"PLoS One"},{"issue":"3","key":"12589_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.molmed.2010.01.002","volume":"16","author":"MK Choy","year":"2010","unstructured":"Choy, M. K. & Phipps, M. E. MICA polymorphism: biology and importance in immunity and disease. Trends Mol. Med. 16(3), 97\u2013106. https:\/\/doi.org\/10.1016\/j.molmed.2010.01.002 (2010).","journal-title":"Trends Mol. Med."},{"key":"12589_CR21","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3389\/fimmu.2018.00620","volume":"9","author":"T Z\u00f6ller","year":"2018","unstructured":"Z\u00f6ller, T., Wittenbrink, M., Hoffmeister, M. & Steinle, A. Cutting an NKG2D ligand short: cellular processing of the peculiar human NKG2D ligand ULBP4. Front. Immunol. 9, 620. https:\/\/doi.org\/10.3389\/fimmu.2018.00620 (2018).","journal-title":"Front. Immunol."},{"key":"12589_CR22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","volume":"31","author":"DH Raulet","year":"2013","unstructured":"Raulet, D. H., Gasser, S., Gowen, B. G., Deng, W. & Jung, H. Regulation of ligands for the NKG2D activating receptor. Annu. Rev. Immunol. 31, 413\u2013441. https:\/\/doi.org\/10.1146\/annurev-immunol-032712-095951 (2013).","journal-title":"Annu. Rev. Immunol."},{"issue":"4\u20135","key":"12589_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.humimm.2008.01.021","volume":"69","author":"JL Fern\u00e1ndez-Morera","year":"2008","unstructured":"Fern\u00e1ndez-Morera, J. L. et al. Soluble MHC class I chain-related protein B serum levels correlate with disease activity in relapsing-remitting multiple sclerosis. Hum. Immunol. 69(4\u20135), 235\u2013240. https:\/\/doi.org\/10.1016\/j.humimm.2008.01.021 (2008).","journal-title":"Hum. Immunol."},{"issue":"4","key":"12589_CR24","first-page":"261","volume":"10","author":"S Abediankenari","year":"2011","unstructured":"Abediankenari, S. et al. MICB gene expression on peripheral blood mononuclear cells and susceptibility to multiple sclerosis in North of Iran. Iran. J. Allergy Asthma Immunol. 10(4), 261\u2013265 (2011).","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"12589_CR25","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.2147\/NDT.S173280","volume":"14","author":"L Cai","year":"2018","unstructured":"Cai, L. & Huang, J. Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study. Neuropsychiatr Dis. Treat. 14, 2241\u20132254. https:\/\/doi.org\/10.2147\/NDT.S173280 (2018).","journal-title":"Neuropsychiatr Dis. Treat."},{"issue":"9","key":"12589_CR26","doi-asserted-by":"publisher","first-page":"e0274565","DOI":"10.1371\/journal.pone.0274565","volume":"17","author":"L Ning","year":"2022","unstructured":"Ning, L. & Wang, B. Neurofilament light chain in blood as a diagnostic and predictive biomarker for multiple sclerosis: a systematic review and meta-analysis. PLoS One. 17(9), e0274565. https:\/\/doi.org\/10.1371\/journal.pone.0274565 (2022).","journal-title":"PLoS One"},{"issue":"9","key":"12589_CR27","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.3174\/ajnr.A6649","volume":"41","author":"M Hosseiny","year":"2020","unstructured":"Hosseiny, M., Newsome, S. D. & Yousem, D. M. Radiologically isolated syndrome: a review for neuroradiologists. AJNR Am. J. Neuroradiol. 41(9), 1542\u20131549. https:\/\/doi.org\/10.3174\/ajnr.A6649 (2020).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"12589_CR28","unstructured":"Montalban, X. Revisions of the McDonald criteria. Presented at ECTRIMS Congress, (2024). September 18\u201320, 2024; Copenhagen, Denmark. Scientific Session 1: New diagnostic criteria."},{"key":"12589_CR29","doi-asserted-by":"publisher","first-page":"123137","DOI":"10.1016\/j.jns.2024.123137","volume":"463","author":"T Nakamura","year":"2024","unstructured":"Nakamura, T. et al. High levels of plasma neurofilament light chain correlated with brainstem and peripheral nerve damage. J. Neurol. Sci. 463, 123137. https:\/\/doi.org\/10.1016\/j.jns.2024.123137 (2024).","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"12589_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12987-022-00403-2","volume":"20","author":"S Engel","year":"2023","unstructured":"Engel, S. et al. Elevated neurofilament light chain csf\/serum ratio indicates impaired CSF outflow in idiopathic intracranial hypertension. Fluids Barriers CNS. 20(1), 3. https:\/\/doi.org\/10.1186\/s12987-022-00403-2 (2023).","journal-title":"Fluids Barriers CNS"},{"key":"12589_CR31","doi-asserted-by":"publisher","first-page":"1493308","DOI":"10.3389\/fnmol.2024.1493308","volume":"17","author":"A Pogoda-Weso\u0142owska","year":"2025","unstructured":"Pogoda-Weso\u0142owska, A. et al. The current state of knowledge on the role of NKG2D ligands in multiple sclerosis and other autoimmune diseases. Front. Mol. Neurosci. 17, 1493308. https:\/\/doi.org\/10.3389\/fnmol.2024.1493308 (2025).","journal-title":"Front. Mol. Neurosci."},{"key":"12589_CR32","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.4049\/jimmunol.172.4.2001","volume":"172","author":"JA Hamerman","year":"2004","unstructured":"Hamerman, J. A., Ogasawara, K. & Lanier, L. L. Cutting edge: toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. J. Immunol. 172, 2001\u20132005. https:\/\/doi.org\/10.4049\/jimmunol.172.4.2001 (2004).","journal-title":"J. Immunol."},{"key":"12589_CR33","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1128\/JVI.79.5.2920-2930.2005","volume":"79","author":"M Hasan","year":"2005","unstructured":"Hasan, M. et al. Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J. Virol. 79, 2920\u20132930. https:\/\/doi.org\/10.1128\/JVI.79.5.2920-2930.2005 (2005).","journal-title":"J. Virol."},{"issue":"5","key":"12589_CR34","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.athoracsur.2015.11.024","volume":"101","author":"AD Althouse","year":"2016","unstructured":"Althouse, A. D. Adjust for multiple comparisons? It\u2019s not that simple. Ann. Thorac. Surg. 101(5), 1644\u20131645. https:\/\/doi.org\/10.1016\/j.athoracsur.2015.11.024 (2016).","journal-title":"Ann. Thorac. Surg."},{"issue":"4","key":"12589_CR35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/s0895-4356(00)00314-0","volume":"54","author":"R Bender","year":"2001","unstructured":"Bender, R. & Lange, S. Adjusting for multiple testing\u2014when and how? J. Clin. Epidemiol. 54(4), 343\u2013349. https:\/\/doi.org\/10.1016\/s0895-4356(00)00314-0 (2001).","journal-title":"J. Clin. Epidemiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12589-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12589-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12589-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:00:02Z","timestamp":1757311202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12589-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12589"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12589-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The manuscript received ethics approval and consent from the Bioethics Commission at the Military Medical Chamber on May 12, 2023, in Warsaw (Resolution No. 9\/23). All methods were performed in accordance with the relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We obtained informed consent from the patients to participate in the study, gather samples, and publish the research results.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"27562"}}